ロード中...
Glucagon‐like peptide‐1 receptor agonists in the era of COVID‐19: Friend or foe?
The aim of the present manuscript is to discuss on potential pros and cons of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) as glucose‐lowering agents during COVID‐19 pandemic, and what is more to evaluate them as potential candidates for the treatment of patients, affected by COVID‐19 infect...
保存先:
| 出版年: | Clin Obes |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995087/ https://ncbi.nlm.nih.gov/pubmed/33423388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cob.12439 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|